Shenzhen Kangtai Biological Products Co., Ltd.
Shenzhen Kangtai Biological Products Co., Ltd.
Share · CNE100002Q33 (XSHE)
Overview
No Price
Closing Price XSHE 11.09.2025: 18,91 CNY
11.09.2025 07:11
1 day
-
1 week
-
1 month
-
3 months
-
6 months
-
Year to date
-
1 year
-
2 years
-
3 years
-
4 years
-
5 years
-
10 years
-
20 years
-
Max
-
Current Prices from Shenzhen Kangtai Biological Products Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHE: SHENZHEN STOCK EXCHANGE
SHENZHEN STOCK EXCHANGE
300601.SZ
CNY
11.09.2025 07:11
18,91 CNY
0,26 CNY
+1,39 %
Invested Funds

The following funds have invested in Shenzhen Kangtai Biological Products Co., Ltd.:

Fund
iShares MSCI China UCITS ETF USD (Dist)
Vol. in million
0,76
Percentage (%)
0,02 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Dist)
Vol. in million
29,98
Percentage (%)
0,01 %
Fund
iShares MSCI EM ESG Enhanced UCITS ETF USD (Acc)
Vol. in million
126,25
Percentage (%)
0,01 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
166,94
Percentage (%)
0,01 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
32,98
Percentage (%)
0,01 %

Company Data

Name Shenzhen Kangtai Biological Products Co., Ltd.
Website https://www.biokangtai.com
Primary Exchange XSHE SHENZHEN STOCK EXCHANGE
ISIN CNE100002Q33
Asset Class Share
Currency CNY

Ticker Symbols

Name Symbol
SHENZHEN STOCK EXCHANGE 300601.SZ
More Shares
Investors who hold Shenzhen Kangtai Biological Products Co., Ltd. also have the following shares in their portfolio:
DOHA FINANCE 25/30 MTN
DOHA FINANCE 25/30 MTN Bond
NEXTERA CAP. 25/55 FLR
NEXTERA CAP. 25/55 FLR Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025